TrialJournal of general internal medicine2018

Quality Improvement and Personalization for Statins: the QUIPS Quality Improvement Randomized Trial of Veterans' Primary Care Statin Use.

Jeremy B Sussman et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 2018

Randomised comparison

Probably raised costs & health-care use

3×1.8× to 4.9×

Bigger than 9 in 10 on the map

As reported

OR 3.0, 95% CI 1.80–4.90

Range includes no effect

No clear effect on costs & health-care use

1.7×1× to 2.8×

Bigger than 8 in 10 on the map

As reported

OR 1.7, 95% CI 0.99–2.77

Two numbers in the abstract

the abstract, start to end

… prescribed an appropriate statin (OR 3.0, 95% CI 1.8-4.9), though the effect resolved after the personalized decision support ended (OR 1.7, 95% CI 0.99-2.77).

← favours treatmentfavours comparator →

could be chance

Costs & health-care use

OR 3.01.80–4.90

Costs & health-care use

OR 1.70.99–2.77

StatinsCosts & health-care use

1 / 3

7 papers cite it

2018

2019

2020

2021

2022

2023

2024

2025

2026

this papertrialcites it

The trial

NCT0282087043 enrolled2016